These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 31250117)
1. GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass. Eriksson O Curr Diab Rep; 2019 Jun; 19(8):49. PubMed ID: 31250117 [TBL] [Abstract][Full Text] [Related]
2. The development of a GPR44 targeting radioligand [ Jahan M; Johnström P; Selvaraju RK; Svedberg M; Winzell MS; Bernström J; Kingston L; Schou M; Jia Z; Skrtic S; Johansson L; Korsgren O; Farde L; Halldin C; Eriksson O EJNMMI Res; 2018 Dec; 8(1):113. PubMed ID: 30588560 [TBL] [Abstract][Full Text] [Related]
3. In Vivo Visualization of β-Cells by Targeting of GPR44. Eriksson O; Johnström P; Cselenyi Z; Jahan M; Selvaraju RK; Jensen-Waern M; Takano A; Sörhede Winzell M; Halldin C; Skrtic S; Korsgren O Diabetes; 2018 Feb; 67(2):182-192. PubMed ID: 29208633 [TBL] [Abstract][Full Text] [Related]
4. PET Imaging of GPR44 by Antagonist [ Cheung P; Zhang B; Puuvuori E; Estrada S; Amin MA; Ye S; Korsgren O; Odell LR; Eriksson J; Eriksson O Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33923731 [TBL] [Abstract][Full Text] [Related]
5. Ramatroban-Based Analogues Containing Fluorine Group as Potential Huang LA; Huang KX; Tu J; Kandeel F; Li J Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801 [TBL] [Abstract][Full Text] [Related]
6. GPR44 is a pancreatic protein restricted to the human beta cell. Hellström-Lindahl E; Danielsson A; Ponten F; Czernichow P; Korsgren O; Johansson L; Eriksson O Acta Diabetol; 2016 Jun; 53(3):413-21. PubMed ID: 26467464 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and preclinical evaluation of the CRTH2 antagonist [ Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767 [TBL] [Abstract][Full Text] [Related]
9. B-Glycine as a marker for β cell imaging and β cell mass evaluation. Han Y; Liu H; Li Y; Liu Z Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2558-2568. PubMed ID: 38632133 [TBL] [Abstract][Full Text] [Related]
10. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond. Murakami T; Fujimoto H; Inagaki N Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856 [TBL] [Abstract][Full Text] [Related]
11. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging. Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633 [TBL] [Abstract][Full Text] [Related]
12. Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic β-cell mass. Cline GW; Zhao X; Jakowski AB; Soeller WC; Treadway JL Biochem Biophys Res Commun; 2011 Sep; 412(3):413-8. PubMed ID: 21820405 [TBL] [Abstract][Full Text] [Related]
13. Species differences in pancreatic binding of DO3A-VS-Cys Eriksson O; Rosenström U; Selvaraju RK; Eriksson B; Velikyan I Acta Diabetol; 2017 Nov; 54(11):1039-1045. PubMed ID: 28891030 [TBL] [Abstract][Full Text] [Related]
14. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease. Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437 [TBL] [Abstract][Full Text] [Related]
15. 11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas. Di Gialleonardo V; Signore A; Scheerstra EA; Visser AK; van Waarde A; Dierckx RA; de Vries EF J Nucl Med; 2012 Nov; 53(11):1755-63. PubMed ID: 23000748 [TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement. Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338 [TBL] [Abstract][Full Text] [Related]
19. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
20. Visualizing pancreatic beta-cell mass with [11C]DTBZ. Simpson NR; Souza F; Witkowski P; Maffei A; Raffo A; Herron A; Kilbourn M; Jurewicz A; Herold K; Liu E; Hardy MA; Van Heertum R; Harris PE Nucl Med Biol; 2006 Oct; 33(7):855-64. PubMed ID: 17045165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]